Rebecca Velez Frey

Directeur/Bestuurslid bij Siduma Therapeutics, Inc.

Health Technology

Finance

Consumer Services

Actieve functies van Rebecca Velez Frey

Bedrijven	Functie	Begin	Einde
Elm Street Advisors LLC Elm Street Advisors LLC Investment ManagersFinance Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut.	Private Equity Investor	01-02-2021	-
Halda Therapeutics LLC Halda Therapeutics LLC Medical/Nursing ServicesHealth Services Halda Therapeutics LLC engages in the development of research-stage drugs for novel therapeutic modality. The company is headquartered New Haven, CT.	Directeur/Bestuurslid	-	-
	Corporate Officer/Principal	-	-
Siduma Therapeutics, Inc. Siduma Therapeutics, Inc. BiotechnologyHealth Technology Siduma Therapeutics, Inc. develops medicines that utilize the body's innate biology.	Directeur/Bestuurslid	01-12-2021	-
	Algemeen Directeur	01-12-2021	-

Loopbaan van Rebecca Velez Frey

Eerdere bekende functies van Rebecca Velez Frey

Bedrijven	Functie	Begin	Einde
Evolveimmune Therapeutics, Inc. Evolveimmune Therapeutics, Inc. BiotechnologyHealth Technology EvolveImmune Therapeutics Inc. engages in the provision of healthcare services. It offers immunotherapy platform to develop molecules for the treatment of oncology and immune diseases. The company was founded in 2019 and is headquartered in Westport, CT.	Operationeel Directeur	01-02-2020	31-12-2021
Cardurion Pharmaceuticals LLC Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA.	Operationeel Directeur	01-01-2018	31-12-2020
ALEXION PHARMACEUTICALS, INC.	President	01-08-2012	30-09-2017
Novartis Inflammasome Research, Inc. Novartis Inflammasome Research, Inc. Pharmaceuticals: MajorHealth Technology Novartis Inflammasome Research, Inc. operates as a biopharmaceutical company, which engages in the development of a suite of NOD-, LRR- and pyrin domain-containing 3 (NLRP3) antagonists for the treatment of inflammatory diseases. It also develops chemically distinct systemic, gut-directed, and central nervous system (CNS)-penetrant drug candidates to address a breadth of indications triggered by NLRP3, including metabolic, fibrotic, autoimmune, autoinflammatory, and neurological diseases. The company was founded by Eicke Latz and Luigi Franchi in 2017 and is headquartered in Boston, MA.	Directeur/Bestuurslid	01-07-2002	30-09-2006

Opleiding van Rebecca Velez Frey

Northeastern University

Undergraduate Degree

Statistieken

Internationaal

Verenigde Staten

Operationeel

Director/Board Member	3
Chief Operating Officer	2
Private Equity Investor	1

Sectoraal

Health Technology	6
Finance	2
Consumer Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Verwante bedrijven

Bedrijven in privébezit	7
Elm Street Advisors LLC Elm Street Advisors LLC Investment ManagersFinance Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut.	Finance
Halda Therapeutics LLC Halda Therapeutics LLC Medical/Nursing ServicesHealth Services Halda Therapeutics LLC engages in the development of research-stage drugs for novel therapeutic modality. The company is headquartered New Haven, CT.	Health Services
Evolveimmune Therapeutics, Inc. Evolveimmune Therapeutics, Inc. BiotechnologyHealth Technology EvolveImmune Therapeutics Inc. engages in the provision of healthcare services. It offers immunotherapy platform to develop molecules for the treatment of oncology and immune diseases. The company was founded in 2019 and is headquartered in Westport, CT.	Health Technology
Novartis Inflammasome Research, Inc. Novartis Inflammasome Research, Inc. Pharmaceuticals: MajorHealth Technology Novartis Inflammasome Research, Inc. operates as a biopharmaceutical company, which engages in the development of a suite of NOD-, LRR- and pyrin domain-containing 3 (NLRP3) antagonists for the treatment of inflammatory diseases. It also develops chemically distinct systemic, gut-directed, and central nervous system (CNS)-penetrant drug candidates to address a breadth of indications triggered by NLRP3, including metabolic, fibrotic, autoimmune, autoinflammatory, and neurological diseases. The company was founded by Eicke Latz and Luigi Franchi in 2017 and is headquartered in Boston, MA.	Health Technology
Cardurion Pharmaceuticals LLC Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA.	Health Technology
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.	Health Technology
Siduma Therapeutics, Inc. Siduma Therapeutics, Inc. BiotechnologyHealth Technology Siduma Therapeutics, Inc. develops medicines that utilize the body's innate biology.	Health Technology

Zie bedrijfsconnecties